TrialPloS one2014

TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial.

Brigitte Dreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.